DIA 2023: What is the CancerX Initiative?

Session provides insight as to how to boost interoperability and expand the middleware on a global scale.

Panel discusses the advantages that these models can provide in adding efficiencies to the clinical trial process.

According to the session panelists, tackling challenges and finding efficiencies is imperative for success.

The presentation expresses the importance of putting the patient at the center of patient recruitment.

Session reveals how organizations can implement DCTs into their clinical trial planning and execution processes.

DeOliveira, senior director, global regulatory operations, Cerevel (now part of AbbVie) highlights her experience in regulatory operations and how to address increased oversight from regulators.